Most molecular biology happens in a handful of human cell lines, and each has a history that shapes what it can and cannot tell you. This is the first of a species-by-species catalogue: for every line, its origin and tissue, the transformation that made it immortal, its karyotype and growth behaviour, and the assays it is — and is not — suited to. Treat it as a selection guide, not a recipe; culture technique is covered separately, and authentication is non-negotiable.
HEK293 and HEK293T
- Species/tissue: Homo sapiens, embryonic kidney; originally described by Graham and colleagues in 1977.
- Origin: human embryonic kidney cells transformed by sheared adenovirus type 5 DNA. The transformation is what makes the line immortal; the adenoviral E1A/E1B functions are retained.
- HEK293T (also 293T) is a derivative carrying the SV40 large T antigen, which allows episomal replication of vectors bearing the SV40 origin — the reason 293T gives very high transient transfection and protein yields. Plain HEK293 lacks large T.
- Growth: adherent, but easily adapted to suspension for large-scale protein production. Grow in DMEM with 10% FBS. Doubling time roughly 24–30 h.
- Typical uses: transient transfection, recombinant protein production, lentivirus/retrovirus packaging, reporter assays, and as a "generic" human cell for signalling. It is a kidney epithelial-like line, so do not treat it as a neuronal or immune model.
- Caveats: the adenoviral E1 genes and SV40 large T perturb p53 and Rb pathways, so the line is not a clean readout of normal cell-cycle or tumour-suppressor biology. Cross-contamination between 293, 293T, and derivative lines is common — authenticate.
HeLa
- Species/tissue: Homo sapiens, cervical adenocarcinoma; established in 1951 by George Gey from a biopsy and reported in 1952. It is the oldest and most widely used human cell line.
- Origin: naturally immortalised cervical tumour, carrying integrated human papillomavirus 18 (HPV-18) sequences. HPV E6 and E7 inactivate p53 and Rb, which underlies both immortality and the line's altered stress and cell-cycle responses.
- Growth: adherent epithelial, robust, fast (doubling ~24 h). Grows in DMEM or MEM + 10% FBS. Highly tolerant of handling — a forgiving line for teaching and assay development.
- Typical uses: general cell biology, proliferation and cytotoxicity assays, microscopy, and as the historical reference line for HeLa-derived work.
- Caveats: the line is notoriously hyper-triploid (a variable, unstable karyotype), so it is a poor choice for karyotype-sensitive or ploidy studies. Its HPV status and long passage history make it a blunt instrument for normal physiology. HeLa has contaminated countless cultures over the decades — the single best reason to authenticate every line you use.
A549
- Species/tissue: Homo sapiens, lung adenocarcinoma; established in 1972 by Giard and colleagues as part of a systematic effort to derive lines from human tumours.
- Origin: a 58-year-old male lung tumour explant; a hypotriploid lung adenocarcinoma line widely used as a type II alveolar epithelial model.
- Growth: adherent, epithelial-like, DMEM or F-12 + 10% FBS. Doubling ~22–24 h.
- Typical uses: lung cancer biology, drug-response and cytotoxicity studies, KRAS-mutant signalling, and as a tumour cell in co-culture and endocytosis/uptake experiments (it is one of the CXCR4-relevant tumour lines in the albumin-nanoparticle work described elsewhere on this site).
- Caveats: it is a cancer line with a mutated background (e.g. KRAS), so it is not a normal lung model. Like all tumour lines it drifts with passage.
HUVEC
- Species/tissue: Homo sapiens, endothelial cells from umbilical vein; the isolation method was published by Jaffe and colleagues in 1973.
- Origin: primary cells harvested from the vein of the human umbilical cord — not an immortalised line. They have a limited lifespan in culture and typically need special endothelial medium (with ECGS/heparin and serum).
- Growth: adherent, cobblestone morphology, best kept at low passage (P2–P6) for physiological relevance.
- Typical uses: angiogenesis and vascular biology, endothelial barrier and permeability assays, leukocyte adhesion, and receptor studies — for example probing gp60-dependent albumin uptake, where methyl-β-cyclodextrin is used to perturb gp60-associated membrane domains.
- Caveats: primary cells senesce, vary between donors and isolations, and lose endothelial phenotype at high passage. Verify markers (CD31, VE-cadherin, vWF) rather than relying on morphology alone.
HepG2
- Species/tissue: Homo sapiens, hepatocellular carcinoma, from a 15-year-old male.
- Origin: a well-differentiated hepatocellular carcinoma line that retains many hepatocyte functions — a workhorse for hepatology and drug metabolism.
- Growth: adherent epithelial, MEM + 10% FBS; forms tight monolayers.
- Typical uses: hepatotoxicity and drug metabolism (cytochrome P450 induction), lipid and lipoprotein biology, hepatitis virus studies, and hepatic gene expression.
- Caveats: despite retaining hepatocyte features it is not primary hepatocytes; drug-metabolising enzyme levels differ from liver, so confirm the specific pathway you rely on.
Choosing among human lines
The decision usually reduces to one question: do you need a clean background or a convenient one?
- Need high protein output or viral packaging → HEK293T.
- Need to teach, run a cytotoxicity assay, or image a robust cell → HeLa.
- Need a lung/tumour or uptake model → A549.
- Need an endothelial/vascular model → HUVEC (primary).
- Need hepatocyte-like metabolism → HepG2.
And whatever you choose, STR-profile it: misidentification and cross-contamination are the most common and most damaging errors in cell biology, and the fix is cheap.
References
- Graham FL, Smiley J, Russell WC, Nairn R. Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol. 1977;36(1):59–72. doi:10.1099/0022-1317-36-1-59
- Giard DJ, Aaronson SA, Todaro GJ, et al. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973;51(5):1417–1423. doi:10.1093/jnci/51.5.1417
- Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: identification by morphologic and immunologic criteria. J Clin Invest. 1973;52(11):2745–2756. doi:10.1172/jci107470
- Azari S, Ahmadi N, Tehrani MJ, Shokri F. Profiling and authentication of human cell lines using short tandem repeat (STR) loci. Biologicals. 2007;35(3):195–202. doi:10.1016/j.biologicals.2006.10.001